Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XWELL operates as a global health and wellness holding company with a portfolio spanning airport spas/services under the “XpresSpa” brand, medical diagnostic testing through “XpresCheck”, digital healthcare/biosurveillance via HyperPointe in partnership with the CDC and Ginkgo Bioworks (“Traveler-based Genomic Surveillance Program”), beauty/skincare through Naples Wax Center, and holistic travel wellness under the Treat brand. The company’s most high-profile initiative is its multi-year CDC contract for pathogen biosurveillance at U.S. airports—a program that has expanded to include both COVID‑19 variants and influenza virus monitoring using wastewater/nasal swab analysis. In parallel to its public health work, it continues to expand consumer-facing spa/wellness operations from airports into city centers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on XWELL.